751 related articles for article (PubMed ID: 25894147)
21. Serial measurements of hepatitis C viral load by real-time polymerase chain reaction among recipients of living-donor renal transplants: a short-term follow-up study from a single center.
Justa S; Minz RW; Minz M; Sharma A; Anand S; Das A; Chawla YK; Sakhuja VK
Transplant Proc; 2010 Nov; 42(9):3568-73. PubMed ID: 21094817
[TBL] [Abstract][Full Text] [Related]
22. Histological evolution of hepatitis C virus infection after renal transplantation.
de Oliveira Uehara SN; Emori CT; da Silva Fucuta Pereira P; Perez RM; Pestana JO; Lanzoni VP; e Silva IS; Silva AE; Ferraz ML
Clin Transplant; 2012; 26(6):842-8. PubMed ID: 22594774
[TBL] [Abstract][Full Text] [Related]
23. Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapy.
Maylin S; Laouénan C; Martinot-Peignoux M; Panhard X; Lapalus M; Nicolas-Chanoine MH; Bedossa P; Asselah T; Marcellin P
J Clin Virol; 2012 Jan; 53(1):43-7. PubMed ID: 22099210
[TBL] [Abstract][Full Text] [Related]
24. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
Leone N; Rizzetto M
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
[TBL] [Abstract][Full Text] [Related]
25. Fibrosing cholestatic hepatitis after successful interferon and ribavirin therapy for recurrent hepatitis C post living related liver transplantation: a case report.
Yamamoto T; Tanaka S; Uenishi T; Kanazawa A; Kubo S; Hirohashi K
Osaka City Med J; 2014 Dec; 60(2):95-100. PubMed ID: 25803885
[TBL] [Abstract][Full Text] [Related]
26. Recurrence of hepatitis C virus (genotype 4) infection after living-donor liver transplant in Egyptian patients.
Yosry A; Abdel-Rahman M; Esmat G; El-Serafy M; Omar A; Doss W; Zayed N; Said M; Ismail T; Hosny A; Marawan E; El-Malt O; Kamel RR; Hatata Y; El-Taweel A; Ghali A; Sabri H; Kamel S; El-Gabaly H
Exp Clin Transplant; 2009 Sep; 7(3):157-63. PubMed ID: 19715525
[TBL] [Abstract][Full Text] [Related]
27. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.
Patton HM; Patel K; Behling C; Bylund D; Blatt LM; Vallée M; Heaton S; Conrad A; Pockros PJ; McHutchison JG
J Hepatol; 2004 Mar; 40(3):484-90. PubMed ID: 15123364
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus and nonliver solid organ transplantation.
Carbone M; Mutimer D; Neuberger J
Transplantation; 2013 Mar; 95(6):779-86. PubMed ID: 23172130
[TBL] [Abstract][Full Text] [Related]
29. [Long-term consequences of co-infection by hepatitis G virus in hepatitis c virus infected kidney transplant patients].
Rostaing L; Izopet J; Arnaud C; Rumeau JL; Duffaut M; Cisterne JM; Durand D
Nephrologie; 1999; 20(3):165-70. PubMed ID: 10418007
[TBL] [Abstract][Full Text] [Related]
30. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
[TBL] [Abstract][Full Text] [Related]
31. Sirolimus conversion may suppress viral replication in hepatitis C virus-positive renal transplant candidates.
Soliman A; Fathy A; Khashab S; Shaheen N; Soliman M
Exp Clin Transplant; 2013 Oct; 11(5):408-11. PubMed ID: 24128134
[TBL] [Abstract][Full Text] [Related]
32. Selection and management of hepatitis C virus-infected patients for the kidney transplant waiting list.
Roth D; Bloom R
Contrib Nephrol; 2012; 176():66-76. PubMed ID: 22310782
[TBL] [Abstract][Full Text] [Related]
33. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.
Stock PG; Roland ME; Carlson L; Freise CE; Roberts JP; Hirose R; Terrault NA; Frassetto LA; Palefsky JM; Tomlanovich SJ; Ascher NL
Transplantation; 2003 Jul; 76(2):370-5. PubMed ID: 12883195
[TBL] [Abstract][Full Text] [Related]
34. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation.
Sterling RK; Sanyal AJ; Luketic VA; Stravitz RT; King AL; Post AB; Mills AS; Contos MJ; Shiffman ML
Am J Gastroenterol; 1999 Dec; 94(12):3576-82. PubMed ID: 10606322
[TBL] [Abstract][Full Text] [Related]
35. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C Virus Infection in Kidney Transplant Patients: Current Treatment Options.
Dzekova-Vidimliski P; Sikole A
Exp Clin Transplant; 2017 Dec; 15(6):587-593. PubMed ID: 29219790
[TBL] [Abstract][Full Text] [Related]
37. Histological features of chronic hepatitis C in haemodialysis patients.
Sakellariou S; Boletis JN; Sypsa V; Psichogiou M; Tiniakos D; Delladetsima I
Liver Int; 2014 Jul; 34(6):e56-61. PubMed ID: 25234282
[TBL] [Abstract][Full Text] [Related]
38. The long-term effects of anti-TNF-α agents on patients with chronic viral hepatitis C and B infections.
Temel T; Cansu DÜ; Korkmaz C; Kaşifoğlu T; Özakyol A
Int J Rheum Dis; 2015 Jan; 18(1):40-5. PubMed ID: 25195983
[TBL] [Abstract][Full Text] [Related]
39. [Outcome of the kidney transplant recipients with chronic hepatitis B virus].
Chen ZY; Lai YT; Huang WJ; Cai YQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):392-5. PubMed ID: 16859131
[TBL] [Abstract][Full Text] [Related]
40. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]